Progress towards the total synthesis of celogentin C

ORGN 735

Joshua S. Grimley, grimley@stanford.edu, Department of Chemistry, Stanford University, Clark Center W300, 318 Campus Drive, Stanford, CA 94305-5441 and Thomas J. Wandless, wandless@stanford.edu, Department of Molecular Pharmacology, Stanford University, Clark Center W350A, 318 Campus Drive, Stanford, CA 94305-5441.
Our studies en route to the synthesis of the antimitotic agent celogentin C will be presented. This bicyclic octapeptide contains novel Leu-Trp-His sidechain connections. We use Larock's indole methodology to construct the tryptophan residue. A nickel-mediated reaction couples a 2-iodoindole to a suitably protected histidine. Current studies include the synthesis of the Larock precursor, an aryl-substituted leucine residue.